QL
SPRY icon

Quarry LP’s ARS Pharmaceuticals SPRY Stock Holding History

Quarry LP’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
+17,724
New +$152K 0.01% 380
2026
Q1 		– Sell
-250
Closed -$2.91K – 2192
2025
Q4 		$2.91K Buy
+250
New +$2.43K ﹤0.01% 1835
2025
Q3 		– Sell
-23,745
Closed -$414K – 2480
2025
Q2 		$414K Sell
23,745
-9,255
-28% -$134K 0.09% 201
2025
Q1 		$415K Buy
+33,000
New +$397K 0.09% 188
2024
Q4 		– Sell
-12,000
Closed -$174K – 1980
2024
Q3 		$174K Buy
+12,000
New +$143K 0.04% 273

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Quarry LP's SPRY Position: Q2 2026 in Review

Quarry LP opened a new position in ARS Pharmaceuticals (SPRY) in Q2 2026: 17,724 shares worth $142K. The stake represents 0.01% of the portfolio and ranks #380 among its holdings. This is a return to the name: Quarry LP previously reported a position in SPRY as recently as Q4 2025.

Quarry LP first reported a position in SPRY in Q3 2024 and has held it in 5 quarters since. The position peaked at $415K in Q1 2025. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Quarry LP held 17,724 shares of ARS Pharmaceuticals worth $142K as of Q2 2026.
  • ARS Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • ARS Pharmaceuticals made up 0.01% of Quarry LP's portfolio in Q2 2026, its #380 holding.
  • Quarry LP first reported a position in ARS Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Quarry LP's ARS Pharmaceuticals position peaked at $415K in Q1 2025.
  • 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.